Metagenomi Therapeutics Inc (MGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -87,868 | -65,340 | -44,947 | -25,039 | -78,058 |
| Depreciation Amortization | 2,105 | 1,275 | 781 | 274 | -2,422 |
| Accounts receivable | 952 | 297 | 384 | 245 | 1,194 |
| Accounts payable and accrued liabilities | 1,054 | 708 | 2,284 | 2,210 | -1,106 |
| Other Working Capital | -22,094 | -15,849 | -10,213 | -2,278 | -59,668 |
| Other Operating Activity | 16,959 | 13,563 | 7,618 | 1,746 | 30,987 |
| Operating Cash Flow | $-88,892 | $-65,346 | $-44,093 | $-22,842 | $-109,073 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -537 | -452 | -378 | -288 | -3,114 |
| Purchase Of Investment | -66,408 | -46,859 | -40,796 | -22,287 | -306,096 |
| Sale Of Investment | 170,474 | 118,474 | 84,974 | 47,303 | 221,053 |
| Investing Cash Flow | $103,529 | $71,163 | $43,800 | $24,728 | $-88,157 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 202 | 109 | 109 | N/A | 84,013 |
| Other Financing Activity | -558 | -539 | -352 | -77 | 0 |
| Financing Cash Flow | $-356 | $-430 | $-243 | $-77 | $84,013 |
| Beginning Cash Position | 32,634 | 32,634 | 32,634 | 32,634 | 145,851 |
| End Cash Position | 46,915 | 38,021 | 32,098 | 34,443 | 32,634 |
| Net Cash Flow | $14,281 | $5,387 | $-536 | $1,809 | $-113,217 |
| Free Cash Flow | |||||
| Operating Cash Flow | -88,892 | -65,346 | -44,093 | -22,842 | -109,073 |
| Capital Expenditure | -574 | -489 | -415 | -288 | -3,114 |
| Free Cash Flow | -89,466 | -65,835 | -44,508 | -23,130 | -112,187 |